http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20181287-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 2016-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6edd9d099785069ccd36ed589c09356
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93582c7ce0d8b00e903aedef5bc93763
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4856c6a90011a3354b90b5aa8a723410
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e95bc4d57299958d320b882cc224ff93
publicationDate 2018-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20181287-A1
titleOfInvention CYANE HAS ANOTHRIAZOLPIRAZINES AND USES OF THE SAME
abstract It refers to cyano thienotriazolepyrazine compounds of formulas I and II, where RA1 is H, halogen, among others; RA2 is H, halogen, among others; X1 is N or CR5; R5 is H, halogen, among others; RB is H, halogen, among others; R1 is H, halogen, alkyl, among others; R2 is H, halogen, alkyl, among others; RC is halogen, alkenyl, among others; ring C is aryl or heteroaryl; RM is -CN, -N (RF) 2; RF is H, optionally substituted alkyl, among others; c is 0, 1, 2, 3, or 4. Also refers to pharmaceutical compositions. Said compounds are bromodomain binding molecules and / or proteins that contain bromodomain and are useful for the treatment of proliferative and cardiovascular diseases, among others.
priorityDate 2015-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655

Total number of triples: 27.